Submitted by Anonymous (not verified) on 15 April 2024 - 12:54
Human medicines European public assessment report (EPAR): Jakavi, ruxolitinib, Date of authorisation: 23/08/2012, Revision: 30, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Jakavi, ruxolitinib, Date of authorisation: 23/08/2012, Revision: 30, Status: Authorised